Home -> Law Blog Directory -> Corporate Governance Blogs -> The Harvard Law School Corporate Governance Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Corporate Governance
: The Harvard Law School Corporate Governance BlogRegulatory Issues in Takeovers: section 13(d) & beyond
By Harvard Law School Program on Corporate Governance
Last week here at Harvard Law School, Professor Robert Clark and Vice Chancellor Leo Strine treated the students of their Mergers, Acquisitions, and Spin-Offs class to another high-profile panel discussing current hot topics in M&A. On the agenda was section 13(d) of the 1934 Act and other, similar disclosure requirements for long and short positions, particularly as they relate to shareholder activism. The steep rise of synthetic securities has raised many questions of policy and interpretation regarding such requirements, as recently highlighted by the CSX/TCI decision (discussed on this blog here, here, and here). The panelists provided competing perspectives on these issues: On the “activist” investor side, the panel featured Roy Katzovicz of Pershing Square Capital Management and Marc Weingarten of Schulte Roth & Zabel. On the other side were Ted Mirvis of Wachtell, Lipton, Rosen & Katz and John Olson of Gibson, Dunn & Crutcher. Mirvis and Olson also spoke about shareholder activism in Professor Lucian Bebchuk’s and Lecturer on Law Beth Young’s Shareholder Activism class that same day. The video of the first event is available here, and that of the second event here.
Full post as published by The Harvard Law School Corporate Governance Blog on November 26, 2008 (boomark / email).
FDA Issues Safety Warning About Valproic Acid and Divalproex Sodium
Valproic Acid and Divalproex Sodium FDA Issues Safety Warning About Risk for Birth Defects
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
FDA Issues Warning about Promethazine Hydrochloride Injection
Promethazine Hydrochloride Injection FDA issues warning
Honda Issues Massive Recalls in US and Canada
Honda Issues Massive Recalls in US and Canada
FDA Issues Early Safety Communication About Meridia Diet Pill
Meridia Diet Pill FDA Issues Early Safety Communication

Bankruptcy, Takeovers, and Bailouts - Oh My!
Takeovers Panel rejects claim in respect of bank share securities
Disclosure of equity derivatives in takeovers
Takeovers Panel Guidance Note on collateral benefits
OTS Regulatory Bulletin: Equal Credit Opportunity Act
An Examination of the Efficiency, Foreclosure, and Collusion Rationales for Vertical Takeovers








